| Year |
Citation |
Score |
| 2019 |
Finan PH, Mun CJ, Epstein DH, Kowalczyk WJ, Phillips KA, Agage D, Smith MT, Preston KL. Multimodal assessment of sleep in men and women during treatment for opioid use disorder. Drug and Alcohol Dependence. 207: 107698. PMID 31816489 DOI: 10.1016/J.Drugalcdep.2019.107698 |
0.325 |
|
| 2019 |
Kleykamp BA, De Santis M, Dworkin RH, Huhn AS, Kampman KM, Montoya ID, Preston KL, Ramey T, Smith SM, Turk DC, Walsh R, Weiss RD, Strain EC. Craving and opioid use disorder: A scoping review. Drug and Alcohol Dependence. 205: 107639. PMID 31683241 DOI: 10.1016/J.Drugalcdep.2019.107639 |
0.374 |
|
| 2019 |
Bertz JW, Epstein DH, Reamer D, Kowalczyk WJ, Phillips KA, Kennedy AP, Jobes ML, Ward G, Plitnick BA, Figueiro MG, Rea MS, Preston KL. Sleep reductions associated with illicit opioid use and clinic-hour changes during opioid agonist treatment for opioid dependence: Measurement by electronic diary and actigraphy. Journal of Substance Abuse Treatment. 106: 43-57. PMID 31540611 DOI: 10.1016/J.Jsat.2019.08.011 |
0.664 |
|
| 2019 |
Panlilio LV, Stull SW, Kowalczyk WJ, Phillips KA, Schroeder JR, Bertz JW, Vahabzadeh M, Lin JL, Mezghanni M, Nunes EV, Epstein DH, Preston KL. Stress, craving and mood as predictors of early dropout from opioid agonist therapy. Drug and Alcohol Dependence. 202: 200-208. PMID 31357121 DOI: 10.1016/J.Drugalcdep.2019.05.026 |
0.426 |
|
| 2019 |
Gardner RA, Epstein DH, Preston KL, Phillips KA. Defining and Predicting Opioid and Cocaine Treatment Response. Substance Use & Misuse. 1-10. PMID 31315479 DOI: 10.1080/10826084.2019.1638405 |
0.418 |
|
| 2019 |
Holtyn AF, Bosworth E, Marsch LA, McLeman B, Meier A, Saunders EC, Ertin E, Ullah MA, Samiei SA, Hossain M, Kumar S, Preston KL, Vahabzadeh M, Shmueli-Blumberg D, Collins J, et al. Towards detecting cocaine use using smartwatches in the NIDA clinical trials network: Design, rationale, and methodology. Contemporary Clinical Trials Communications. 15: 100392. PMID 31245651 DOI: 10.1016/J.Conctc.2019.100392 |
0.416 |
|
| 2019 |
Stull SW, Panlilio LV, Moran LM, Schroeder JR, Bertz JW, Epstein DH, Preston KL, Phillips KA. The chippers, the quitters, and the highly symptomatic: A 12-month longitudinal study of DSM-5 opioid- and cocaine-use problems in a community sample. Addictive Behaviors. 96: 183-191. PMID 31108264 DOI: 10.1016/J.Addbeh.2019.04.030 |
0.413 |
|
| 2019 |
Spagnolo PA, Kimes A, Schwandt ML, Shokri-Kojori E, Thada S, Phillips KA, Diazgranados N, Preston KL, Herscovitch P, Tomasi D, Ramchandani VA, Heilig M. Striatal Dopamine Release in Response to Morphine: A [C]-Raclopride Positron Emission Tomography Study in Healthy Men. Biological Psychiatry. PMID 31097294 DOI: 10.1016/J.Biopsych.2019.03.965 |
0.308 |
|
| 2019 |
Crist R, Phillips K, Furnari M, Moran L, Doyle G, Zhang A, McNicholas L, Cornish J, Kampman K, Preston K, Berrettini W. SA107A FUNCTIONAL OPRD1 VARIANT PREDICTS BUPRENORPHINE EFFICACY IN AFRICAN-AMERICANS WITH OPIOID USE DISORDER European Neuropsychopharmacology. 29: S1247-S1248. DOI: 10.1016/J.Euroneuro.2018.08.329 |
0.314 |
|
| 2019 |
Crist R, Zhang A, Doyle G, Preston K, Furnari M, Moran L, McNicholas L, Kampman K, Cornish J, Phillips K, Berrettini W. An Oprd1 Variant Predicts Continued Opioid Use In African-Americans Undergoing Buprenorphine Treatment European Neuropsychopharmacology. 29. DOI: 10.1016/J.Euroneuro.2017.08.277 |
0.383 |
|
| 2018 |
Crist RC, Phillips KA, Furnari MA, Moran LM, Doyle GA, McNicholas LF, Cornish JW, Kampman KM, Preston KL, Berrettini WH. Replication of the pharmacogenetic effect of rs678849 on buprenorphine efficacy in African-Americans with opioid use disorder. The Pharmacogenomics Journal. PMID 30368523 DOI: 10.1038/S41397-018-0065-X |
0.352 |
|
| 2018 |
Preston KL, Schroeder JR, Kowalczyk WJ, Phillips KA, Jobes ML, Dwyer M, Vahabzadeh M, Lin JL, Mezghanni M, Epstein DH. End-of-day reports of daily hassles and stress in men and women with opioid-use disorder: Relationship to momentary reports of opioid and cocaine use and stress. Drug and Alcohol Dependence. 193: 21-28. PMID 30336389 DOI: 10.1016/J.Drugalcdep.2018.08.023 |
0.723 |
|
| 2018 |
Phillips KA, Preston KL. Prevention and Treatment of Opioid Overdose and Opioid-Use Disorders. Addictive Behaviors. 86: 1-3. PMID 30080480 DOI: 10.1016/J.Addbeh.2018.07.013 |
0.353 |
|
| 2018 |
Schroeder JR, Phillips KA, Epstein DH, Jobes ML, Furnari MA, Kennedy AP, Heilig M, Preston KL. Assessment of pioglitazone and proinflammatory cytokines during buprenorphine taper in patients with opioid use disorder. Psychopharmacology. PMID 30079432 DOI: 10.1007/S00213-018-4986-5 |
0.676 |
|
| 2018 |
Preston KL, Kowalczyk WJ, Phillips KA, Jobes ML, Vahabzadeh M, Lin JL, Mezghanni M, Epstein DH. Before and after: craving, mood, and background stress in the hours surrounding drug use and stressful events in patients with opioid-use disorder. Psychopharmacology. PMID 29980821 DOI: 10.1007/S00213-018-4966-9 |
0.706 |
|
| 2018 |
Moran LM, Kowalczyk WJ, Phillips KA, Vahabzadeh M, Lin JL, Mezghanni M, Epstein DH, Preston KL. Sex differences in daily life stress and craving in opioid-dependent patients. The American Journal of Drug and Alcohol Abuse. 1-12. PMID 29641291 DOI: 10.1080/00952990.2018.1454934 |
0.374 |
|
| 2018 |
Kowalczyk WJ, Moran LM, Bertz JW, Phillips KA, Ghitza UE, Vahabzadeh M, Lin JL, Epstein DH, Preston KL. Using ecological momentary assessment to examine the relationship between craving and affect with opioid use in a clinical trial of clonidine as an adjunct medication to buprenorphine treatment. The American Journal of Drug and Alcohol Abuse. 1-10. PMID 29634425 DOI: 10.1080/00952990.2018.1454933 |
0.382 |
|
| 2017 |
Bertz JW, Epstein DH, Preston KL. Combining ecological momentary assessment with objective, ambulatory measures of behavior and physiology in substance-use research. Addictive Behaviors. PMID 29174666 DOI: 10.1016/J.Addbeh.2017.11.027 |
0.338 |
|
| 2017 |
Preston KL, Kowalczyk WJ, Phillips KA, Jobes ML, Vahabzadeh M, Lin JL, Mezghanni M, Epstein DH. Exacerbated Craving in the Presence of Stress and Drug Cues in Drug-Dependent Patients. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 29105663 DOI: 10.1038/Npp.2017.275 |
0.733 |
|
| 2017 |
Kowalczyk WJ, Bertz JW, Moran LM, Phillips KA, Ghitza UE, Epstein DH, Preston KL. Clonidine Increases the Likelihood That Abstinence Can Withstand Unstructured Time in Buprenorphine-maintained Outpatients. Journal of Addiction Medicine. PMID 28759482 DOI: 10.1097/Adm.0000000000000345 |
0.387 |
|
| 2017 |
Preston KL, Kowalczyk WJ, Phillips KA, Jobes ML, Vahabzadeh M, Lin JL, Mezghanni M, Epstein DH. Context and craving during stressful events in the daily lives of drug-dependent patients. Psychopharmacology. PMID 28593441 DOI: 10.1007/S00213-017-4663-0 |
0.696 |
|
| 2017 |
Carmona-Rivera C, Purmalek MM, Moore E, Waldman M, Walter PJ, Garraffo HM, Phillips KA, Preston KL, Graf J, Kaplan MJ, Grayson PC. A role for muscarinic receptors in neutrophil extracellular trap formation and levamisole-induced autoimmunity. Jci Insight. 2: e89780. PMID 28194438 DOI: 10.1172/Jci.Insight.89780 |
0.343 |
|
| 2017 |
Preston KL, Phillips KA, Wagner JJ, Cummings B, Epstein DH. History of cocaine sensitization in humans is associated with lipidomic changes similar to those in cocaine-sensitized rats Drug and Alcohol Dependence. 171: e168. DOI: 10.1016/J.Drugalcdep.2016.08.462 |
0.355 |
|
| 2017 |
Moran L, Phillips KA, Kowalczyk WJ, Ghitza U, Epstein DH, Preston KL. Cue-induced cocaine craving increases with aripiprazole treatment in methadone-maintenance patients Drug and Alcohol Dependence. 171: e148-e149. DOI: 10.1016/J.Drugalcdep.2016.08.410 |
0.383 |
|
| 2017 |
Bertz JW, Epstein DH, Rea M, Figueiro MG, Ward G, Preston KL. Measuring circadian entrainment during outpatient opioid agonist maintenance Drug and Alcohol Dependence. 171: e20. DOI: 10.1016/J.Drugalcdep.2016.08.069 |
0.325 |
|
| 2016 |
Moran LM, Phillips KA, Kowalczyk WJ, Ghitza UE, Agage DA, Epstein DH, Preston KL. Aripiprazole for cocaine abstinence: a randomized-controlled trial with ecological momentary assessment. Behavioural Pharmacology. PMID 27755017 DOI: 10.1097/Fbp.0000000000000268 |
0.39 |
|
| 2016 |
Epstein DH, Kennedy AP, Furnari M, Heilig M, Shaham Y, Phillips KA, Preston KL. Effect of the CRF1-receptor antagonist pexacerfont on stress-induced eating and food craving. Psychopharmacology. PMID 27595147 DOI: 10.1007/S00213-016-4424-5 |
0.311 |
|
| 2016 |
Preston KL, Jobes ML, Phillips KA, Epstein DH. Real-time assessment of alcohol drinking and drug use in opioid-dependent polydrug users. Behavioural Pharmacology. 27: 579-84. PMID 27579810 DOI: 10.1097/Fbp.0000000000000250 |
0.691 |
|
| 2016 |
Grayson P, Carmona-Rivera C, Graf J, Irizarry-Caro J, Phillips K, Preston K, Purmalek M, Subramaniam V, Thompson P, Waldman M, Kaplan M. OP0054 Neuroimmunomodulation of Neutrophils as A Novel Mechanism of Levamisole-Induced Vasculitis Annals of the Rheumatic Diseases. 75: 74.3-75. DOI: 10.1136/Annrheumdis-2016-Eular.2963 |
0.331 |
|
| 2015 |
Jobes ML, Aharonovich E, Epstein DH, Phillips KA, Reamer D, Anderson M, Preston KL. Effects of Prereactivation Propranolol on Cocaine Craving Elicited by Imagery Script/Cue Sets in Opioid-dependent Polydrug Users: A Randomized Study. Journal of Addiction Medicine. 9: 491-8. PMID 26501788 DOI: 10.1097/Adm.0000000000000169 |
0.69 |
|
| 2015 |
Furnari M, Epstein DH, Phillips KA, Jobes ML, Kowalczyk WJ, Vahabzadeh M, Lin JL, Preston KL. Some of the people, some of the time: field evidence for associations and dissociations between stress and drug use. Psychopharmacology. PMID 26153066 DOI: 10.1007/S00213-015-3998-7 |
0.69 |
|
| 2015 |
Kennedy AP, Epstein DH, Jobes ML, Agage D, Tyburski M, Phillips KA, Ali AA, Bari R, Hossain SM, Hovsepian K, Rahman MM, Ertin E, Kumar S, Preston KL. Continuous in-the-field measurement of heart rate: Correlates of drug use, craving, stress, and mood in polydrug users. Drug and Alcohol Dependence. 151: 159-66. PMID 25920802 DOI: 10.1016/J.Drugalcdep.2015.03.024 |
0.684 |
|
| 2015 |
Epstein DH, Preston KL. No evidence for reduction of opioid-withdrawal symptoms by cannabis smoking during a methadone dose taper. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 24: 323-8. PMID 25846329 DOI: 10.1111/Ajad.12183 |
0.303 |
|
| 2015 |
Kowalczyk WJ, Phillips KA, Jobes ML, Kennedy AP, Ghitza UE, Agage DA, Schmittner JP, Epstein DH, Preston KL. Clonidine Maintenance Prolongs Opioid Abstinence and Decouples Stress From Craving in Daily Life: A Randomized Controlled Trial With Ecological Momentary Assessment. The American Journal of Psychiatry. appiajp201414081014. PMID 25783757 DOI: 10.1176/Appi.Ajp.2014.14081014 |
0.72 |
|
| 2015 |
Preston KL, Kennedy A, Jobes ML, Phillips KA, Agage D, Tyburski M, Kumar S, Epstein D. Ambulatory field measurement of heart rate in opioid/cocaine users Drug and Alcohol Dependence. 156: e180. DOI: 10.1016/J.Drugalcdep.2015.07.490 |
0.69 |
|
| 2015 |
Phillips KA, Louie D, Furnari MA, Kowalczyk WJ, Epstein D, Preston KL. Trait, state, and place: The role of personality and environment in drug use Drug and Alcohol Dependence. 156: e177. DOI: 10.1016/J.Drugalcdep.2015.07.480 |
0.3 |
|
| 2015 |
Kowalczyk WJ, Furnari MA, Phillips KA, Jobes ML, Ghitza U, Epstein D, Preston KL. Reducing the cost of free time: Treatment success in a randomized trial of clonidine as adjunct to buprenorphine maintenance is associated with more leisure activities in the clonidine condition Drug and Alcohol Dependence. 156: e118. DOI: 10.1016/j.drugalcdep.2015.07.326 |
0.608 |
|
| 2015 |
Kowalczyk WJ, Furnari MA, Phillips KA, Jobes ML, Ghitza U, Epstein D, Preston KL. Reducing the cost of free time: Treatment success in a randomized trial of clonidine as adjunct to buprenorphine maintenance is associated with more leisure activities in the clonidine condition Drug and Alcohol Dependence. 156: e118. DOI: 10.1016/J.Drugalcdep.2015.07.326 |
0.635 |
|
| 2015 |
Furnari MA, Kowalczyk WJ, Jobes ML, Phillips KA, Epstein D, Preston KL. Field evidence for stress-induced drug use Drug and Alcohol Dependence. 156: e75-e76. DOI: 10.1016/J.Drugalcdep.2015.07.1123 |
0.685 |
|
| 2015 |
Preston KL, Tyburski M, Phillips KA, Jobes ML, Furr-Holden C, Vahabzadeh M, Mezghanni M, Lin J, Epstein DH. Predicting mood and craving from real-time neighborhood surroundings Drug and Alcohol Dependence. 146: e73. DOI: 10.1016/J.Drugalcdep.2014.09.567 |
0.627 |
|
| 2015 |
Phillips KA, Epstein D, Jobes ML, Preston KL. Smartphone-reported stress and drug events and day-end perceived stress, hassles, and mood in methadone-maintained individuals Drug and Alcohol Dependence. 146: e69. DOI: 10.1016/J.Drugalcdep.2014.09.557 |
0.684 |
|
| 2015 |
Jobes ML, Epstein DH, Phillips KA, Preston KL. Connecting states and traits: A look at personality and response to stress in real-time Drug and Alcohol Dependence. 146: e148. DOI: 10.1016/J.Drugalcdep.2014.09.320 |
0.643 |
|
| 2015 |
Furnari MA, Jobes ML, Phillips KA, Epstein D, Preston KL. Real-time stress, craving and mood differences in polydrug-using methadone treatment responders and nonresponders Drug and Alcohol Dependence. 146: e283. DOI: 10.1016/J.Drugalcdep.2014.09.237 |
0.68 |
|
| 2014 |
Rahman M, Bari R, Ali AA, Sharmin M, Raij A, Hovsepian K, Hossain SM, Ertin E, Kennedy A, Epstein DH, Preston KL, Jobes M, Beck JG, Kedia S, Ward KD, et al. Are We There Yet? Feasibility of Continuous Stress Assessment via Wireless Physiological Sensors. Acm-Bcb ... ... : the ... Acm Conference On Bioinformatics, Computational Biology and Biomedicine. Acm Conference On Bioinformatics, Computational Biology and Biomedicine. 2014: 479-488. PMID 25821861 DOI: 10.1145/2649387.2649433 |
0.649 |
|
| 2014 |
Phillips KA, Epstein DH, Vahabzadeh M, Mezghanni M, Lin JL, Preston KL. Substance use and hepatitis C: an ecological momentary assessment study. Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association. 33: 710-9. PMID 24977312 DOI: 10.1037/Hea0000087 |
0.31 |
|
| 2014 |
Phillips KA, Epstein DH, Preston KL. Psychostimulant addiction treatment. Neuropharmacology. 87: 150-60. PMID 24727297 DOI: 10.1016/J.Neuropharm.2014.04.002 |
0.336 |
|
| 2014 |
Epstein DH, Tyburski M, Craig IM, Phillips KA, Jobes ML, Vahabzadeh M, Mezghanni M, Lin JL, Furr-Holden CD, Preston KL. Real-time tracking of neighborhood surroundings and mood in urban drug misusers: application of a new method to study behavior in its geographical context. Drug and Alcohol Dependence. 134: 22-9. PMID 24332365 DOI: 10.1016/J.Drugalcdep.2013.09.007 |
0.651 |
|
| 2014 |
Kennedy A, Rea M, Figueiro M, Jobes ML, Epstein D, Preston KL. Daysimeter feasibility and acceptability in a polysubstance-using population Drug and Alcohol Dependence. 140: e101. DOI: 10.1016/J.Drugalcdep.2014.02.292 |
0.604 |
|
| 2014 |
Harrell PT, Epstein D, Preston KL. Place and drug craving: An ecological momentary assessment study Drug and Alcohol Dependence. 140: e80. DOI: 10.1016/J.Drugalcdep.2014.02.237 |
0.33 |
|
| 2013 |
Phillips KA, Epstein DH, Preston KL. Daily temporal patterns of heroin and cocaine use and craving: relationship with business hours regardless of actual employment status. Addictive Behaviors. 38: 2485-91. PMID 23770647 DOI: 10.1016/J.Addbeh.2013.05.010 |
0.418 |
|
| 2013 |
Kennedy AP, Epstein DH, Phillips KA, Preston KL. Sex differences in cocaine/heroin users: drug-use triggers and craving in daily life. Drug and Alcohol Dependence. 132: 29-37. PMID 23357742 DOI: 10.1016/J.Drugalcdep.2012.12.025 |
0.391 |
|
| 2013 |
Kennedy AP, Phillips KA, Epstein DH, Reamer DA, Schmittner J, Preston KL. A randomized investigation of methadone doses at or over 100 mg/day, combined with contingency management. Drug and Alcohol Dependence. 130: 77-84. PMID 23195924 DOI: 10.1016/J.Drugalcdep.2012.10.025 |
0.313 |
|
| 2012 |
Phillips KA, Hirsch GA, Epstein DH, Preston KL. Cardiac complications of unwitting co-injection of quinine/quinidine with heroin in an intravenous drug user. Journal of General Internal Medicine. 27: 1722-5. PMID 22592353 DOI: 10.1007/S11606-012-2089-2 |
0.33 |
|
| 2012 |
Epstein DH, Preston KL. TGI Monday?: drug-dependent outpatients report lower stress and more happiness at work than elsewhere. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 21: 189-98. PMID 22494220 DOI: 10.1111/J.1521-0391.2012.00230.X |
0.445 |
|
| 2012 |
Bigelow GE, Preston KL, Schmittner J, Dong Q, Gastfriend DR. Opioid challenge evaluation of blockade by extended-release naltrexone in opioid-abusing adults: Dose-effects and time-course Drug and Alcohol Dependence. 123: 57-65. PMID 22079773 DOI: 10.1016/J.Drugalcdep.2011.10.018 |
0.356 |
|
| 2012 |
Donovan DM, Bigelow GE, Brigham GS, Carroll KM, Cohen AJ, Gardin JG, Hamilton JA, Huestis MA, Hughes JR, Lindblad R, Marlatt GA, Preston KL, Selzer JA, Somoza EC, Wakim PG, et al. Primary outcome indices in illicit drug dependence treatment research: systematic approach to selection and measurement of drug use end-points in clinical trials. Addiction (Abingdon, England). 107: 694-708. PMID 21781202 DOI: 10.1111/J.1360-0443.2011.03473.X |
0.338 |
|
| 2011 |
Jobes ML, Ghitza UE, Epstein DH, Phillips KA, Heishman SJ, Preston KL. Clonidine blocks stress-induced craving in cocaine users. Psychopharmacology. 218: 83-8. PMID 21399902 DOI: 10.1007/S00213-011-2230-7 |
0.714 |
|
| 2011 |
Preston KL, Epstein DH. Stress in the daily lives of cocaine and heroin users: relationship to mood, craving, relapse triggers, and cocaine use. Psychopharmacology. 218: 29-37. PMID 21336579 DOI: 10.1007/S00213-011-2183-X |
0.462 |
|
| 2011 |
Harrell PT, Montoya ID, Preston KL, Juliano LM, Gorelick DA. Cigarette smoking and short-term addiction treatment outcome Drug and Alcohol Dependence. 115: 161-166. PMID 21163592 DOI: 10.1016/J.Drugalcdep.2010.08.017 |
0.376 |
|
| 2011 |
Bedi G, Preston KL, Epstein DH, Heishman SJ, Marrone GF, Shaham Y, de Wit H. Incubation of cue-induced cigarette craving during abstinence in human smokers. Biological Psychiatry. 69: 708-11. PMID 20817135 DOI: 10.1016/J.Biopsych.2010.07.014 |
0.336 |
|
| 2010 |
Ghitza UE, Preston KL, Epstein DH, Kuwabara H, Endres CJ, Bencherif B, Boyd SJ, Copersino ML, Frost JJ, Gorelick DA. Brain mu-opioid receptor binding predicts treatment outcome in cocaine-abusing outpatients. Biological Psychiatry. 68: 697-703. PMID 20579973 DOI: 10.1016/J.Biopsych.2010.05.003 |
0.401 |
|
| 2010 |
Epstein DH, Preston KL. Daily life hour by hour, with and without cocaine: An ecological momentary assessment study Psychopharmacology. 211: 223-232. PMID 20532873 DOI: 10.1007/S00213-010-1884-X |
0.432 |
|
| 2010 |
Epstein DH, Marrone GF, Heishman SJ, Schmittner J, Preston KL. Tobacco, cocaine, and heroin: Craving and use during daily life. Addictive Behaviors. 35: 318-24. PMID 19939575 DOI: 10.1016/J.Addbeh.2009.11.003 |
0.363 |
|
| 2009 |
Preston KL, Vahabzadeh M, Schmittner J, Lin JL, Gorelick DA, Epstein DH. Cocaine craving and use during daily life. Psychopharmacology. 207: 291-301. PMID 19777216 DOI: 10.1007/S00213-009-1655-8 |
0.419 |
|
| 2009 |
Schmittner J, Schroeder JR, Epstein DH, Krantz MJ, Eid NC, Preston KL. Electrocardiographic effects of lofexidine and methadone coadministration: secondary findings from a safety study. Pharmacotherapy. 29: 495-502. PMID 19397459 DOI: 10.1592/Phco.29.5.495 |
0.302 |
|
| 2009 |
Epstein DH, Willner-Reid J, Vahabzadeh M, Mezghanni M, Lin JL, Preston KL. Real-time electronic diary reports of cue exposure and mood in the hours before cocaine and heroin craving and use. Archives of General Psychiatry. 66: 88-94. PMID 19124692 DOI: 10.1001/Archgenpsychiatry.2008.509 |
0.403 |
|
| 2009 |
Epstein DH, Schmittner J, Umbricht A, Schroeder JR, Moolchan ET, Preston KL. Promoting abstinence from cocaine and heroin with a methadone dose increase and a novel contingency. Drug and Alcohol Dependence. 101: 92-100. PMID 19101098 DOI: 10.1016/J.Drugalcdep.2008.11.006 |
0.432 |
|
| 2009 |
Heinz AJ, Wu J, Witkiewitz K, Epstein DH, Preston KL. Marriage and relationship closeness as predictors of cocaine and heroin use. Addictive Behaviors. 34: 258-63. PMID 19008050 DOI: 10.1016/J.Addbeh.2008.10.020 |
0.422 |
|
| 2008 |
Preston KL, Ghitza UE, Schmittner JP, Schroeder JR, Epstein DH. Randomized trial comparing two treatment strategies using prize-based reinforcement of abstinence in cocaine and opiate users. Journal of Applied Behavior Analysis. 41: 551-63. PMID 19192859 DOI: 10.1901/Jaba.2008.41-551 |
0.381 |
|
| 2008 |
Ghitza UE, Epstein DH, Schmittner J, Vahabzadeh M, Lin JL, Preston KL. Effect of reinforcement probability and prize size on cocaine and heroin abstinence in prize-based contingency management. Journal of Applied Behavior Analysis. 41: 539-49. PMID 19192858 DOI: 10.1901/Jaba.2008.41-539 |
0.379 |
|
| 2008 |
Ghitza UE, Epstein DH, Preston KL. Self-report of illicit benzodiazepine use on the Addiction Severity Index predicts treatment outcome. Drug and Alcohol Dependence. 97: 150-7. PMID 18499354 DOI: 10.1016/J.Drugalcdep.2008.04.003 |
0.41 |
|
| 2008 |
Ghitza UE, Epstein DH, Preston KL. Contingency management reduces injection-related HIV risk behaviors in heroin and cocaine using outpatients. Addictive Behaviors. 33: 593-604. PMID 18068905 DOI: 10.1016/J.Addbeh.2007.11.009 |
0.372 |
|
| 2007 |
Ghitza UE, Epstein DH, Schmittner J, Vahabzadeh M, Lin JL, Preston KL. Randomized trial of prize-based reinforcement density for simultaneous abstinence from cocaine and heroin. Journal of Consulting and Clinical Psychology. 75: 765-74. PMID 17907858 DOI: 10.1037/0022-006X.75.5.765 |
0.382 |
|
| 2007 |
Ghitza UE, Epstein DH, Preston KL. Psychosocial functioning and cocaine use during treatment: strength of relationship depends on type of urine-testing method. Drug and Alcohol Dependence. 91: 169-77. PMID 17624688 DOI: 10.1016/J.Drugalcdep.2007.05.018 |
0.4 |
|
| 2007 |
Heinz A, Epstein DH, Preston KL. Spiritual/religious experiences and in-treatment outcome in an inner-city program for heroin and cocaine dependence Journal of Psychoactive Drugs. 39: 41-49. PMID 17523584 DOI: 10.1080/02791072.2007.10399863 |
0.386 |
|
| 2007 |
Ghitza UE, Epstein DH, Preston KL. Nonreporting of cannabis use: Predictors and relationship to treatment outcome in methadone maintained patients. Addictive Behaviors. 32: 938-49. PMID 16887281 DOI: 10.1016/J.Addbeh.2006.06.034 |
0.43 |
|
| 2006 |
Heinz AJ, Epstein DH, Schroeder JR, Singleton EG, Heishman SJ, Preston KL. Heroin and cocaine craving and use during treatment: measurement validation and potential relationships. Journal of Substance Abuse Treatment. 31: 355-64. PMID 17084789 DOI: 10.1016/J.Jsat.2006.05.009 |
0.385 |
|
| 2006 |
Epstein DH, Preston KL, Stewart J, Shaham Y. Toward a model of drug relapse: an assessment of the validity of the reinstatement procedure. Psychopharmacology. 189: 1-16. PMID 17019567 DOI: 10.1007/S00213-006-0529-6 |
0.346 |
|
| 2006 |
Carroll CP, Walsh SL, Bigelow GE, Strain EC, Preston KL. Assessment of agonist and antagonist effects of tramadol in opioid-dependent humans Experimental and Clinical Psychopharmacology. 14: 109-120. PMID 16756415 DOI: 10.1037/1064-1297.14.2.109 |
0.402 |
|
| 2006 |
Epstein DH, Preston KL, Jasinski DR. Abuse liability, behavioral pharmacology, and physical-dependence potential of opioids in humans and laboratory animals: Lessons from tramadol Biological Psychology. 73: 90-99. PMID 16497429 DOI: 10.1016/J.Biopsycho.2006.01.010 |
0.343 |
|
| 2006 |
Schroeder JR, Epstein DH, Umbricht A, Preston KL. Changes in HIV risk behaviors among patients receiving combined pharmacological and behavioral interventions for heroin and cocaine dependence. Addictive Behaviors. 31: 868-79. PMID 16085366 DOI: 10.1016/J.Addbeh.2005.07.009 |
0.362 |
|
| 2005 |
Schroeder JR, Schmittner JP, Epstein DH, Preston KL. Adverse events among patients in a behavioral treatment trial for heroin and cocaine dependence: effects of age, race, and gender. Drug and Alcohol Dependence. 80: 45-51. PMID 16157230 DOI: 10.1016/J.Drugalcdep.2005.03.007 |
0.353 |
|
| 2005 |
Montoya ID, Schroeder JR, Preston KL, Covi L, Umbricht A, Contoreggi C, Fudala PJ, Johnson RE, Gorelick DA. Influence of psychotherapy attendance on buprenorphine treatment outcome. Journal of Substance Abuse Treatment. 28: 247-54. PMID 15857725 DOI: 10.1016/J.Jsat.2005.01.004 |
0.396 |
|
| 2005 |
SCHMITTNER J, SCHROEDER J, EPSTEIN D, PRESTON K. Adverse events in a behavioral treatment trial in methadone maintenance Clinical Pharmacology & Therapeutics. 77: P71-P71. DOI: 10.1016/J.Clpt.2004.12.164 |
0.378 |
|
| 2004 |
Schmittner J, Schroeder JR, Epstein DH, Preston KL. QT interval increased after single dose of lofexidine. Bmj (Clinical Research Ed.). 329: 1075. PMID 15528619 DOI: 10.1136/Bmj.329.7474.1075 |
0.38 |
|
| 2004 |
Boyd SJ, Thomas-Gosain NF, Umbricht A, Tucker MJ, Leslie JM, Chaisson RE, Preston KL. Gender differences in indices of opioid dependency and medical comorbidity in a population of hospitalized HIV-infected African-Americans. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 13: 281-91. PMID 15370947 DOI: 10.1080/10550490490459960 |
0.31 |
|
| 2004 |
Umbricht A, Huestis MA, Cone EJ, Preston KL. Effects of high-dose intravenous buprenorphine in experienced opioid abusers Journal of Clinical Psychopharmacology. 24: 479-487. PMID 15349002 DOI: 10.1097/01.Jcp.0000138766.15858.C6 |
0.397 |
|
| 2004 |
Preston KL, Umbricht A, Schroeder JR, Abreu ME, Epstein DH, Pickworth WB. Cyclazocine: comparison to hydromorphone and interaction with cocaine. Behavioural Pharmacology. 15: 91-102. PMID 15096909 DOI: 10.1097/00008877-200403000-00001 |
0.439 |
|
| 2004 |
Montoya ID, Gorelick DA, Preston KL, Schroeder JR, Umbricht A, Cheskin LJ, Lange WR, Contoreggi C, Johnson RE, Fudala PJ. Randomized trial of buprenorphine for treatment of concurrent opiate and cocaine dependence. Clinical Pharmacology and Therapeutics. 75: 34-48. PMID 14749690 DOI: 10.1016/J.Clpt.2003.09.004 |
0.419 |
|
| 2004 |
Preston K. Differential effects of methadone dose/contingency management combinations on abstinence from heroin and cocaine Clinical Pharmacology & Therapeutics. 75: P21. DOI: 10.1016/J.Clpt.2003.11.079 |
0.405 |
|
| 2003 |
Schroeder JR, Gupman AE, Epstein DH, Umbricht A, Preston KL. Do noncontingent vouchers increase drug use? Experimental and Clinical Psychopharmacology. 11: 195-201. PMID 12940498 DOI: 10.1037/1064-1297.11.3.195 |
0.43 |
|
| 2003 |
Epstein DH, Preston KL. The reinstatement model and relapse prevention: A clinical perspective Psychopharmacology. 168: 31-41. PMID 12721778 DOI: 10.1007/S00213-003-1470-6 |
0.347 |
|
| 2003 |
Epstein DH, Hawkins WE, Covi L, Umbricht A, Preston KL. Cognitive-behavioral therapy plus contingency management for cocaine use: Findings during treatment and across 12-month follow-up Psychology of Addictive Behaviors. 17: 73-82. PMID 12665084 DOI: 10.1037/0893-164X.17.1.73 |
0.392 |
|
| 2003 |
Umbricht A, Hoover DR, Tucker MJ, Leslie JM, Chaisson RE, Preston KL. Opioid detoxification with buprenorphine, clonidine, or methadone in hospitalized heroin-dependent patients with HIV infection. Drug and Alcohol Dependence. 69: 263-72. PMID 12633912 DOI: 10.1016/S0376-8716(02)00325-3 |
0.323 |
|
| 2003 |
Herning RI, Better WE, Tate K, Umbricht A, Preston KL, Cadet JL. Methadone treatment induces attenuation of cerebrovascular deficits associated with the prolonged abuse of cocaine and heroin. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 28: 562-8. PMID 12629538 DOI: 10.1038/Sj.Npp.1300073 |
0.372 |
|
| 2003 |
Epstein DH, Preston KL. Does cannabis use predict poor outcome for heroin-dependent patients on maintenance treatment? Past findings and more evidence against Addiction. 98: 269-279. PMID 12603227 DOI: 10.1046/J.1360-0443.2003.00310.X |
0.419 |
|
| 2002 |
Preston KL, Epstein DH, Cone EJ, Wtsadik AT, Huestis MA, Moolchan ET. Urinary elimination of cocaine metabolites in chronic cocaine users during cessation Journal of Analytical Toxicology. 26: 393-400. PMID 12422991 DOI: 10.1093/Jat/26.7.393 |
0.366 |
|
| 2002 |
Covi L, Hess JM, Schroeder JR, Preston KL. A dose response study of cognitive behavioral therapy in cocaine abusers. Journal of Substance Abuse Treatment. 23: 191-7. PMID 12392805 DOI: 10.1016/S0740-5472(02)00247-7 |
0.399 |
|
| 2002 |
Preston KL, Umbricht A, Epstein DH. Abstinence reinforcement maintenance contingency and one-year follow-up Drug and Alcohol Dependence. 67: 125-137. PMID 12095662 DOI: 10.1016/S0376-8716(02)00023-6 |
0.336 |
|
| 2002 |
Cone EJ, Preston KL. Toxicologic aspects of heroin substitution treatment Therapeutic Drug Monitoring. 24: 193-198. PMID 11897965 DOI: 10.1097/00007691-200204000-00001 |
0.369 |
|
| 2002 |
Montoya ID, Preston KL, Rothman R, Gorelick DA. Open-label pilot study of bupropion plus bromocriptine for treatment of cocaine dependence American Journal of Drug and Alcohol Abuse. 28: 189-196. PMID 11853133 DOI: 10.1081/Ada-120001288 |
0.41 |
|
| 2001 |
Spanbauer AC, Casseday S, Davoudzadeh D, Preston KL, Huestis MA. Detection of opiate use in a methadone maintenance treatment population with the CEDIA® 6-acetylmorphine and CEDIA DAU opiate assays Journal of Analytical Toxicology. 25: 515-519. PMID 11599593 DOI: 10.1093/Jat/25.7.515 |
0.339 |
|
| 2001 |
Preston KL, Umbricht A, Wong CJ, Epstein DH. Shaping cocaine abstinence by successive approximation Journal of Consulting and Clinical Psychology. 69: 643-654. PMID 11550730 DOI: 10.1037//0022-006X.69.4.643 |
0.37 |
|
| 2001 |
Pickens RW, Preston KL, Miles DR, Gupman AE, Johnson EO, Newlin DB, Soriano J, van den Bree MB, Umbricht A. Family history influence on drug abuse severity and treatment outcome. Drug and Alcohol Dependence. 61: 261-70. PMID 11164690 DOI: 10.1016/S0376-8716(00)00146-0 |
0.396 |
|
| 2000 |
Huestis MA, Cone EJ, Wong CJ, Umbricht A, Preston KL. Monitoring opiate use in substance abuse treatment patients with sweat and urine drug testing Journal of Analytical Toxicology. 24: 509-521. PMID 11043653 DOI: 10.1093/Jat/24.7.509 |
0.34 |
|
| 2000 |
Moolchan ET, Cone EJ, Wstadik A, Huestis MA, Preston KL. Cocaine and metabolite elimination patterns in chronic cocaine users during cessation: Plasma and saliva analysis Journal of Analytical Toxicology. 24: 458-466. PMID 11043647 DOI: 10.1093/Jat/24.7.458 |
0.375 |
|
| 2000 |
Hall GW, Carriero NJ, Takushi RY, Montoya ID, Preston KL, Gorelick DA. Pathological gambling among cocaine-dependent outpatients American Journal of Psychiatry. 157: 1127-1133. PMID 10873922 DOI: 10.1176/Appi.Ajp.157.7.1127 |
0.404 |
|
| 2000 |
Preston KL, Umbricht A, Epstein DH. Methadone dose increase and abstinence reinforcement for treatment of continued heroin use during methadone maintenance Archives of General Psychiatry. 57: 395-404. PMID 10768702 DOI: 10.1001/Archpsyc.57.4.395 |
0.342 |
|
| 2000 |
Robles E, Silverman K, Preston KL, Cone EJ, Katz E, Bigelow GE, Stitzer ML. The brief abstinence test: voucher-based reinforcement of cocaine abstinence. Drug and Alcohol Dependence. 58: 205-12. PMID 10669073 DOI: 10.1016/S0376-8716(99)00090-3 |
0.378 |
|
| 1999 |
Epstein DH, Silverman K, Henningfield JE, Preston KL. Low-dose oral cocaine in humans: acquisition of discrimination and time-course of effects. Behavioural Pharmacology. 10: 531-42. PMID 10780259 DOI: 10.1097/00008877-199909000-00011 |
0.425 |
|
| 1999 |
Umbricht A, Montoya ID, Hoover DR, Demuth KL, Chiang CT, Preston KL. Naltrexone shortened opioid detoxification with buprenorphine. Drug and Alcohol Dependence. 56: 181-90. PMID 10529020 DOI: 10.1016/S0376-8716(99)00033-2 |
0.321 |
|
| 1999 |
Preston KL, Huestis MA, Wong CJ, Umbricht A, Goldberger BA, Cone EJ. Monitoring cocaine use in substance-abuse-treatment patients by sweat and urine testing Journal of Analytical Toxicology. 23: 313-322. PMID 10488917 DOI: 10.1093/Jat/23.5.313 |
0.366 |
|
| 1999 |
Preston KL, Silverman K, Umbricht A, DeJesus A, Montoya ID, Schuster CR. Improvement in naltrexone treatment compliance with contingency management. Drug and Alcohol Dependence. 54: 127-35. PMID 10217552 DOI: 10.1016/S0376-8716(98)00152-5 |
0.312 |
|
| 1999 |
Johanson CE, Preston K. The influence of an instruction on the stimulus effects of drugs in humans. Experimental and Clinical Psychopharmacology. 6: 427-32. PMID 9861557 DOI: 10.1037//1064-1297.6.4.427 |
0.326 |
|
| 1999 |
Preston KL, Huestis MA, Wong CJ, Cone EJ. Urine and sweat monitoring of illicit opiate use Clinical Pharmacology and Therapeutics. 65: 153. DOI: 10.1016/S0009-9236(99)80142-8 |
0.332 |
|
| 1998 |
Preston KL, Bigelow GE. Opioid discrimination in humans: discriminative and subjective effects of progressively lower training dose. Behavioural Pharmacology. 9: 533-43. PMID 9862079 DOI: 10.1097/00008877-199811000-00009 |
0.326 |
|
| 1998 |
Preston KL, Goldberger BA, Cone EJ. Occurrence of cocaine in urine of substance-abuse treatment patients Journal of Analytical Toxicology. 22: 580-586. PMID 9847008 DOI: 10.1093/Jat/22.7.580 |
0.389 |
|
| 1998 |
Silverman K, Wong CJ, Umbricht-Schneiter A, Montoya ID, Schuster CR, Preston KL. Broad beneficial effects of cocaine abstinence reinforcement among methadone patients. Journal of Consulting and Clinical Psychology. 66: 811-24. PMID 9803700 DOI: 10.1037/0022-006X.66.5.811 |
0.389 |
|
| 1998 |
Preston KL, Silverman K, Higgins ST, Brooner RK, Montoya I, Schuster CR, Cone EJ. Cocaine use early in treatment predicts outcome in a behavioral treatment program. Journal of Consulting and Clinical Psychology. 66: 691-6. PMID 9735588 DOI: 10.1037//0022-006X.66.4.691 |
0.4 |
|
| 1998 |
Schlaepfer TE, Strain EC, Greenberg BD, Preston KL, Lancaster E, Bigelow GE, Barta PE, Pearlson GD. Site of opioid action in the human brain: mu and kappa agonists' subjective and cerebral blood flow effects. The American Journal of Psychiatry. 155: 470-3. PMID 9545990 DOI: 10.1176/Ajp.155.4.470 |
0.309 |
|
| 1997 |
Preston KL, Silverman K, Schuster CR, Cone EJ. Assessment of cocaine use with quantitative urinalysis and estimation of new uses. Addiction (Abingdon, England). 92: 717-27. PMID 9246799 DOI: 10.1111/J.1360-0443.1997.Tb02938.X |
0.412 |
|
| 1997 |
Sullivan JT, Becker PM, Preston KL, Wise RA, Wigely FM, Testa MP, Jasinski DR. Cocaine effects on digital blood flow and diffusing capacity for carbon monoxide among chronic cocaine users. The American Journal of Medicine. 102: 232-8. PMID 9217590 DOI: 10.1016/S0002-9343(96)00453-6 |
0.33 |
|
| 1997 |
Dykstra LA, Preston KL, Bigelow GE. Discriminative stimulus and subjective effects of opioids with mu and kappa activity: data from laboratory animals and human subjects. Psychopharmacology. 130: 14-27. PMID 9089845 DOI: 10.1007/S002130050208 |
0.343 |
|
| 1997 |
Strain EC, Walsh SL, Preston KL, Liebson IA, Bigelow GE. The effects of buprenorphine in buprenorphine-maintained volunteers Psychopharmacology. 129: 329-338. PMID 9085402 DOI: 10.1007/S002130050199 |
0.393 |
|
| 1996 |
Sullivan JT, Preston KL, Testa MP, Bell J, Jasinski DR. 5-HT3 receptor antagonism and psychoactivity. Journal of Psychopharmacology (Oxford, England). 10: 182-7. PMID 22302943 DOI: 10.1177/026988119601000302 |
0.385 |
|
| 1996 |
Oyler J, Darwin WD, Preston KL, Suess P, Cone EJ. Cocaine disposition in meconium from newborns of cocaine-abusing mothers and urine of adult drug users Journal of Analytical Toxicology. 20: 453-462. PMID 8889682 DOI: 10.1093/Jat/20.6.453 |
0.367 |
|
| 1996 |
Strain EC, Preston KL, Liebson IA, Bigelow GE. Opioid antagonist effects of dezocine in opioid-dependent humans Clinical Pharmacology and Therapeutics. 60: 206-217. PMID 8823239 DOI: 10.1016/S0009-9236(96)90137-X |
0.385 |
|
| 1996 |
Silverman K, Wong CJ, Higgins ST, Brooner RK, Montoya ID, Contoreggi C, Umbricht-Schneiter A, Schuster CR, Preston KL. Increasing opiate abstinence through voucher-based reinforcement therapy. Drug and Alcohol Dependence. 41: 157-65. PMID 8809505 DOI: 10.1016/0376-8716(96)01246-X |
0.338 |
|
| 1996 |
Preston KL, Sullivan JT, Strain EC, Bigelow GE. Enhancement of cocaine's abuse liability in methadone maintenance patients Psychopharmacology. 123: 15-25. PMID 8741950 |
0.334 |
|
| 1996 |
Silverman K, Higgins ST, Brooner RK, Montoya ID, Cone EJ, Schuster CR, Preston KL. Sustained cocaine abstinence in methadone maintenance patients through voucher-based reinforcement therapy. Archives of General Psychiatry. 53: 409-15. PMID 8624184 DOI: 10.1001/Archpsyc.1996.01830050045007 |
0.392 |
|
| 1996 |
Montoya ID, Preston KL, Cone EJ, Rothman R, Gorelick DA. Safety and Efficacy of Bupropion Combined With Bromocriptine for Treatment of Cocaine Dependence The American Journal On Addictions. 5: 69-75. DOI: 10.1111/J.1521-0391.1996.Tb00286.X |
0.411 |
|
| 1996 |
Preston K, Silverman K, Schuster C, Cone E. Baseline Cocaine Use Predicts Outcome in Cocaine Treatment Clinical Pharmacology & Therapeutics. 59: 210-210. DOI: 10.1038/Sj.Clpt.1996.338 |
0.377 |
|
| 1995 |
Montoya ID, Hess JM, Preston KL, Gorelick DA. A model for pharmacological research-treatment of cocaine dependence Journal of Substance Abuse Treatment. 12: 415-421. PMID 8749725 DOI: 10.1016/0740-5472(95)02017-9 |
0.382 |
|
| 1995 |
Walsh SL, June HL, Schuh KJ, Preston KL, Bigelow GE, Stitzer ML. Effects of buprenorphine and methadone in methadone-maintained subjects. Psychopharmacology. 119: 268-76. PMID 7675960 DOI: 10.1007/Bf02246290 |
0.379 |
|
| 1995 |
Montoya ID, Umbricht A, Preston KL. Buprenorphine for human immunovirus-positive opiate-dependent patients Biological Psychiatry. 38: 135-136. PMID 7578651 DOI: 10.1016/0006-3223(95)00071-N |
0.395 |
|
| 1995 |
Walsh SL, June HL, Schuh KJ, Preston KL, Bigelow G, Stitzer ML. Erratum: Effects of buprenorphine and methadone in methadone-maintained subjects (Psychopharmacology (1994) 119 (268-276)) Psychopharmacology. 121. DOI: 10.1007/Bf02246503 |
0.311 |
|
| 1994 |
Walsh SL, Preston KL, Stitzer ML, Cone EJ, Bigelow GE. Clinical pharmacology of buprenorphine: ceiling effects at high doses. Clinical Pharmacology and Therapeutics. 55: 569-80. PMID 8181201 DOI: 10.1097/00132586-199502000-00012 |
0.367 |
|
| 1994 |
Preston KL, Sullivan JT, Testa M, Jasinski DR. Psychopharmacology and abuse potential of transnasal butorphanol Drug and Alcohol Dependence. 35: 159-167. PMID 8055737 DOI: 10.1016/0376-8716(94)90123-6 |
0.374 |
|
| 1994 |
Walsh SL, Gilson SF, Jasinski DR, Stapleton JM, Phillips RL, Dannals RF, Schmidt J, Preston KL, Grayson R, Bigelow GE, Sullivan JT, Contoreggi C, London ED. Buprenorphine reduces cerebral glucose metabolism in poly drug abusers Neuropsychopharmacology. 10: 157-170. PMID 7916913 DOI: 10.1038/Npp.1994.18 |
0.353 |
|
| 1994 |
Walsh SL, Preston KL, Sullivan JT, Fromme R, Bigelow GE. Fluoxetine alters the effects of intravenous cocaine in humans Journal of Clinical Psychopharmacology. 14: 396-407. PMID 7884020 DOI: 10.1097/00004714-199412000-00005 |
0.417 |
|
| 1994 |
Strain EC, Preston KL, Stitzer ML, Liebson IA, Bigelow GE. The effects of cocaine in buprenorphine-maintained outpatient volunteers. Results from clinical experience and laboratory challenges American Journal On Addictions. 3: 129-143. DOI: 10.3109/10550499409117246 |
0.428 |
|
| 1994 |
Strain EC, Preston KL, Stitzer ML, Liebson IA, Bigelow GE. The Effects of Cocaine in Buprenorphine-Maintained Outpatient Volunteers The American Journal On Addictions. 3: 129-143. DOI: 10.1111/J.1521-0391.1994.Tb00380.X |
0.427 |
|
| 1992 |
Higgins ST, Preston KL, Cone EJ, Henningfield JE, Jaffe JH. Supersensitivity to naloxone following acute morphine pretreatment in humans: behavioral, hormonal and physiological effects. Drug and Alcohol Dependence. 30: 13-26. PMID 1591977 DOI: 10.1016/0376-8716(92)90031-7 |
0.362 |
|
| 1992 |
Weinhold LL, Preston KL, Farre M, Liebson IA, Bigelow GE. Buprenorphine alone and in combination with naloxone in non-dependent humans Drug and Alcohol Dependence. 30: 263-274. PMID 1396108 DOI: 10.1016/0376-8716(92)90061-G |
0.396 |
|
| 1992 |
Sullivan JT, Preston KL, Testa MP, Busch M, Jasinski DR. Psychoactivity and abuse potential of sumatriptan Clinical Pharmacology and Therapeutics. 52: 635-642. PMID 1333934 DOI: 10.1038/Clpt.1992.202 |
0.41 |
|
| 1991 |
Preston KL, Funderburk FR, Liebson IA, Bigelow GE. Evaluation of the abuse potential of the novel analgesic flupirtine maleate Drug and Alcohol Dependence. 27: 101-113. PMID 2055157 DOI: 10.1016/0376-8716(91)90027-V |
0.37 |
|
| 1991 |
Preston KL, Jasinski DR, Testa M. Abuse potential and pharmacological comparison of tramadol and morphine Drug and Alcohol Dependence. 27: 7-17. PMID 2029860 DOI: 10.1016/0376-8716(91)90081-9 |
0.396 |
|
| 1991 |
Preston KL, Jasinski DR. Abuse liability studies of opioid agonist-antagonists in humans Drug and Alcohol Dependence. 28: 49-82. PMID 1884671 DOI: 10.1016/0376-8716(91)90053-2 |
0.431 |
|
| 1991 |
Preston KL. Drug abstinence effects: Opioids British Journal of Addiction. 86: 1641-1646. PMID 1786495 DOI: 10.1111/J.1360-0443.1991.Tb01759.X |
0.389 |
|
| 1991 |
Preston KL. Drug discrimination methods in human drug abuse liability evaluation British Journal of Addiction. 86: 1587-1594. PMID 1786491 DOI: 10.1111/J.1360-0443.1991.Tb01752.X |
0.353 |
|
| 1990 |
Preston KL, Bigelow GE, Liebson IA. Effects of sublingually given naloxone in opioid-dependent human volunteers Drug and Alcohol Dependence. 25: 27-34. PMID 2323306 DOI: 10.1016/0376-8716(90)90136-3 |
0.39 |
|
| 1990 |
Preston KL, Bigelow GE, Liebson IA. Discrimination of butorphanol and nalbuphine in opioid-dependent humans Pharmacology, Biochemistry and Behavior. 37: 511-522. PMID 1708145 DOI: 10.1016/0091-3057(90)90021-9 |
0.381 |
|
| 1990 |
Bigelow GE, Preston KL. Opioid drug discriminations in humans Pharmacology Biochemistry and Behavior. 36: 429. DOI: 10.1016/0091-3057(90)90456-R |
0.369 |
|
| 1988 |
Preston KL, Bigelow GE, Liebson IA. Buprenorphine and naloxone alone and in combination in opioid-dependent humans Psychopharmacology. 94: 484-490. PMID 2453895 DOI: 10.1007/Bf00212842 |
0.381 |
|
| 1987 |
Jasinski DR, Preston KL. A comparative assay of nefopam, morphine and d-amphetamine Psychopharmacology. 91: 273-278. PMID 3104949 DOI: 10.1007/Bf00518176 |
0.372 |
|
| 1986 |
Jasinski DR, Preston KL. Evaluation of tilidine for morphine-like subjective effects and euphoria Drug and Alcohol Dependence. 18: 273-292. PMID 3803198 DOI: 10.1016/0376-8716(86)90059-1 |
0.356 |
|
| 1986 |
Jasinski DR, Preston KL. Comparison of intravenously administered methadone, morphine and heroin Drug and Alcohol Dependence. 17: 301-310. PMID 3757766 DOI: 10.1016/0376-8716(86)90079-7 |
0.405 |
|
| 1986 |
Jasinski DR, Preston KL. Evaluation of mixtures of morphine and d-amphetamine for subjective and physiological effects Drug and Alcohol Dependence. 17: 1-13. PMID 3720527 DOI: 10.1016/0376-8716(86)90031-1 |
0.39 |
|
| 1986 |
Preston KL, Griffiths RR, Cone EJ, Darwin WD, Gorodetzky CW. Diazepam and methadone blood levels following concurrent administration of diazepam and methadone Drug and Alcohol Dependence. 18: 195-202. PMID 3096681 DOI: 10.1016/0376-8716(86)90051-7 |
0.359 |
|
| 1985 |
Preston KL, Schuster CR, Seiden LS. Methamphetamine, physostigmine, atropine and mecamylamine: effects on force lever performance. Pharmacology, Biochemistry, and Behavior. 23: 781-8. PMID 4080764 DOI: 10.1016/0091-3057(85)90072-3 |
0.301 |
|
| 1985 |
Preston KL, Bigelow GE. Pharmacological advances in addiction treatment International Journal of the Addictions. 20: 845-867. PMID 2867050 DOI: 10.3109/10826088509047756 |
0.349 |
|
| 1985 |
Jasinski DR, Preston KL. Assessment of dezocine for morphine-like subjective effects and miosis Clinical Pharmacology and Therapeutics. 38: 544-548. PMID 2865027 DOI: 10.1038/Clpt.1985.221 |
0.41 |
|
| 1985 |
Preston KL, Wagner GC, Schuster CR, Seiden LS. Long-term effects of repeated methylamphetamine administration on monoamine neurons in the rhesus monkey brain. Brain Research. 338: 243-8. PMID 2411342 DOI: 10.1016/0006-8993(85)90153-2 |
0.512 |
|
| 1985 |
Preston KL, Bigelow GE, Liebson IA. Self-administration of clonidine, oxazepam, and hydromorphone by patients undergoing methadone detoxification Clinical Pharmacology and Therapeutics. 38: 219-227. PMID 2410178 DOI: 10.1038/Clpt.1985.162 |
0.386 |
|
| 1984 |
Preston KL, Wagner GC, Seiden LS, Schuster CR. Effects of methamphetamine on atropine-induced conditioned gustatory avoidance. Pharmacology, Biochemistry, and Behavior. 20: 601-7. PMID 6728875 DOI: 10.1016/0091-3057(84)90310-1 |
0.526 |
|
| 1984 |
Preston KL, Griffiths RR, Stitzer ML, Bigelow GE, Liebson IA. Diazepam and methadone interactions in methadone maintenance. Clinical Pharmacology and Therapeutics. 36: 534-41. PMID 6478738 DOI: 10.1038/Clpt.1984.215 |
0.375 |
|
| 1982 |
Wagner GC, Preston K, Ricaurte GA, Schuster CR, Seiden LS. Neurochemical similarities between d,l-cathinone and d-amphetamine. Drug and Alcohol Dependence. 9: 279-84. PMID 7128450 DOI: 10.1016/0376-8716(82)90067-9 |
0.508 |
|
| 1981 |
Foltin RW, Preston KL, Wagner GC, Schuster CR. The aversive stimulus properties of repeated infusions of cocaine. Pharmacology, Biochemistry, and Behavior. 15: 71-4. PMID 7291234 DOI: 10.1016/0091-3057(81)90341-5 |
0.605 |
|
| Show low-probability matches. |